Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis

Published:2017-11-09 Issue:1 Volume:16 Page:65-77
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Barriere Paul,Porcu-Buisson Géraldine,Hamamah Samir

Funder

Ferring SAS France

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

http://link.springer.com/article/10.1007/s40258-017-0361-7/fulltext.html

Reference21 articles.

1. ESHRE ART fact sheet (October 2016). Available from: https://www.eshre.eu/Press-Room/Resources.aspx . Accessed 23 February 2017.

2. Biomedicine Agency (2015). Available from: https://www.agence-biomedecine.fr/annexes/bilan2015/donnees/procreation/01-amp/synthese.htm . Accessed 25 February 2017.

3. Biomedicine Agency (2017). Available from: https://www.procreation-medicale.fr . Accessed 23 February 2017.

4. Advanced Fertility Center of Chicago (AFCC). Ovarian Stimulation IVF Protocols Medications and Drugs for In Vitro Fertilization. Available at: http://www.advancedfertility.com/ivfstim.htm . Accessed 23 February 2017.

5. Service Public France. Assistance médicale à la procréation (AMP). Available at: https://www.service-public.fr/particuliers/vosdroits/F31462 . Accessed 23 February 2017.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues – Critical appraisal on “Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France”;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2024-09

2. Economic evaluation of GnRH-agonist long protocol and GnRH-antagonist protocol in IVT/ICSI among the Chinese population: using pharmacoeconomic models;BMJ Open;2024-08

3. Feasibility analysis of China's medical insurance coverage of assisted reproductive technology;Scientific Reports;2024-04-05

4. Economic evaluations of assisted reproductive technologies in high-income countries: a systematic review;Human Reproduction;2024-03-04

5. A direct healthcare cost analysis of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol;Archives of Gynecology and Obstetrics;2023-12-15